Your browser doesn't support javascript.
loading
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.
Forns, Xavier; Colom, Joan; García-Retortillo, Montse; Quer, Joan Carles; Lens, Sabela; Martró, Elisa; Domínguez-Hernández, Raquel; Casado, Miguel Ángel; Buti, María.
Afiliação
  • Forns X; Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Colom J; CIBERehd, Instituto Carlos III, Barcelona, Spain.
  • García-Retortillo M; Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis, Programme on Substance Abuse, Agency of Public Health of Catalonia, Barcelona, Spain.
  • Quer JC; Department of Gastroenterology, Liver Section, Hospital del Mar, Barcelona, Spain.
  • Lens S; Gastroenterology Department, University Hospital Joan XXIII, Tarragona, Spain.
  • Martró E; Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Domínguez-Hernández R; CIBERehd, Instituto Carlos III, Barcelona, Spain.
  • Casado MÁ; Microbiology Department, Laboratori Clínic Metropolitana Nord. Hospital Universitari Germans Trias i Pujol. Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Buti M; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III. Madrid, Spain.
J Viral Hepat ; 29(3): 227-230, 2022 03.
Article em En | MEDLINE | ID: mdl-34806812
ABSTRACT
According to WHO goals, the elimination of Hepatitis C Virus (HCV) by 2030 requires enhancing and simplifying HCV testing. Our aim was to create a model to assess and compare different strategies for HCV testing, linkage to care and treatment among people who access harm reduction centres (HRC) and Addiction Centres in Catalonia. A decision tree model was designed to evaluate two strategies Hepatitis C Point-of-care (POC) "test and treat", at the community versus standard-of-care (SOC), in which HCV testing was performed at community and therapy at the hospital. Both strategies were assessed separately in HRCs (6,878 users) and Addiction Centres (13,778 users). with a time horizon of 18 months. Healthcare outcomes were HCV testing, linkage to care, treatment outcomes and reinfection rate. HCV testing was performed in 3,178 (46%) of the HRC users. Compared with SOC, POC increased access to treatment by 57% (63% vs. 6%). SVR rates were 64% in POC vs. 23% in SOC. Reinfection rates were 21% with POC compared to 24% with SOC. With POC, losses to follow-up were reduced by 41%. In the Addiction Centres, 12,566 users (91%) were screened using the two strategies. Compared to the SOC, POC increased access to treatment and linkage to care by 19% along with SVR at the same rate. Reinfection rates decreased by 6%. Thus, the implementation of a POC "test and treat" strategy at HRCs and Addiction Centres has shown to be an effective public health strategy to help eliminating HCV in accordance with WHO goal.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abuso de Substâncias por Via Intravenosa / Hepatite C Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abuso de Substâncias por Via Intravenosa / Hepatite C Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha